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Abstract
Background: T cell-mediated immunity in elderly people is compromised in ways reflected in the
composition of the peripheral T cell pool. The advent of polychromatic flow cytometry has made
analysis of cell subsets feasible in unprecedented detail.
Results: Here we document shifts in subset distribution within naïve (N), central memory (CM)
and effector memory (EM) cells defined by CD45RA and CCR7 expression in the elderly,
additionally using the costimulatory receptors CD27 and CD28, as well as the coinhibitory
receptors CD57 and KLRG-1, to further dissect these. Although differences between young and
old were more marked in CD8 than in CD4 cells, a similar overall pattern prevailed in both. Thus,
the use of all these markers together, and inclusion of assays of proliferation and cytokine
secretion, may enable the construction of a differentiation scheme applicable to CD4 as well as
CD8 cells, with the model (based on Romer o  e t  a l . )  s u g g e s t i n g  t h e  p r o g r e s s i o n
N→CM→EM1→EM2→pE1→pE2→EM4→EM3→E end-stage non-proliferative effector cells.
Conclusion:  Overall, the results suggest that both differences in subset distribution and
differences between subsets are responsible for age-related changes in CD8 cells but that
differences within rather than between subsets are more prominent for CD4 cells.
Background
Numerous studies have established that many parameters
of immunity are decreased in elderly people and suggest
that these are likely to contribute to their increased sus-
ceptibility to infectious disease and poor responses to vac-
cination [1-3]. In particular, the ability to control disease
caused by novel pathogens is greatly compromised;
responses to previously-encountered pathogens are, how-
ever, also eventually eroded in the very elderly [4]. These
findings could be explained in at least two mutually non-
exclusive ways: 1) that each T cell from an elderly donor is
in some way compromised in its function, or 2) the pro-
portions of the different T cell subsets differ between
young and old people, but the function of each cell type is
the same regardless of donor age. There is evidence for
both views in that single T cells from the elderly may, for
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example, show apparent defects in signal transduction
and activation [5]. However, most earlier studies exam-
ined mixed cell populations and apparent differences
could have been due to different proportions of cells in
the test populations. Studies with monoclonal popula-
tions have indicated age-associated changes at the single
cell level [6], but these were associated with culture not
chronological age and their relevance to the in vivo situa-
tion remains open.
It is clear that age-associated thymic involution results in
markedly decreased, but generally not absent, production
of naïve T cells [7], while memory cell numbers increase
in response to encountered pathogens [8]. The definition
of "naïve" and "memory" cells in humans, is, however,
controversial [9], and several models have been proposed
based on cell surface expression of constellations of recep-
tors and other molecules [10-12]. It must be borne in
mind that these are all conceptual models and that line-
ages in this sense are not fixed; rather T cells are in a
dynamic state of differentiation. One such model divides
CD8 cells on the basis of their expression of the leukocyte
common antigen isoform CD45RA and the chemokine
receptor CCR7 into naïve (N; CD45RA+ CCR7+), "cen-
tral" memory (CM; CD 45RA- CCR7+), "effector" mem-
ory (EM; CD45RA- CCR7-) and "terminally
differentiated" effector memory (TEMRA; CD45RA+
CCR7-) cells [13]. Within each of these populations, the
expression of the major T cell costimulatory receptors
CD27, belonging to the TNF receptor family, and CD28,
belonging to the B7 receptor family, has been applied to
identify more (CD27- CD28-) or less (CD27+CD28+,
CD27-CD28+ or CD27+CD28-) differentiated cells [14],
schematically depicted in Figure 1. Differences between
these T cell populations in young and old people have not
yet been reported, but could provide useful data to dis-
criminate between competing hypotheses to explain T cell
changes in the elderly, namely whether these are caused
entirely by altered frequencies of different cell subsets or
by altered properties of cells within each of the subsets.
This is a problem which has rendered interpretation of
comparative data problematic over the years [5]. Here, we
have employed polychromatic flow cytometry to investi-
gate the frequencies of these different T cell subsets in
young and old donors, examining both CD8 cells, as well
as extending the above models to CD4 cells. Moreover, we
have also included two other putative markers of highly
differentiated T cells into this analysis, CD57 and Killer
Lectin-like receptor G1 (KLRG1). The latter is an inhibi-
tory C-type lectin-like receptor, a dimeric type-II trans-
membrane glycoprotein with an extracellular domain
homologous to C-type lectins and a cytoplasmic tail con-
taining an immunoreceptor tyrosine-based inhibition
motive (ITIM). KLRG1 is expressed on αβ T cells as well as
NK cells [15] and γδ T cells [16] and was suggested to iden-
tify replicatively senescent cells [15,17]. CD57, the human
natural killer-1 (HNK-1) glycoprotein, is found on many
NK cells but also a subset of CD8 cells, where it has been
reported to identify terminally differentiated T cells with
reduced proliferative capacity [18,18]. In a more recent
study, Ibegbu et al. showed that only CD57+ KLRG1+
double-positive T cells were impaired in their ability to
proliferate [19]. The results presented here confirm that
compared to the young, PBMC from the elderly contain
decreased percentages naïve CD8 cells and increased
TEMRA cells, while CD4 cells show similar but less
marked trends. When dissected by their concurrent
expression of CD27 and CD28, these subsets of T cells
show further differences between young and old within
subsets of CD8 cells and again fewer differences for CD4
cells. However, when CD57 and KLRG-1 are applied as
additional markers of differentiation, greater age-associ-
ated disparities within CD4 subsets than CD8 subsets
become apparent. These data are therefore consistent both
with the existence of major differences between young
and elderly donors residing in the altered frequencies of
the different subsets and differences within those subsets,
and re-emphasize that CD4 and CD8 cells show different
age-associated changes in humans.
Schematic model of the T cell differentiation subsets using  the markers CCR7 and CD45RA and the co-stimulatory  molecules CD27 and CD28 Figure 1
Schematic model of the T cell differentiation subsets 
using the markers CCR7 and CD45RA and the co-
stimulatory molecules CD27 and CD28. With protein 
tyrosine phosphatase isoform CD45RA and the chemokine 
receptor CCR7, T cells can be subdivided into 
CD45RA+CCR7+ naïve (N), CD45RA-CCR7+ central mem-
ory (CM), CD45RA-CCR7- effector memory (EM) and 
CD45RA+CCR7- terminally differentiated effector memory 
(TEMRA) cells. The main subsets can be further subdivided 
by their expression of the co-stimulatory molecules TNF-
family receptor CD27 and B7-family receptor CD28. Here, 
N and CM cells were defined as CD27+CD28+, whereas in 
EM and TEMRA further populations can be distinguished, 
which within EM cells are CD27+CD28+ (EM1), 
CD27+CD28- (EM2), CD27-CD28- (EM 3) and CD27-
CD28+ (EM4), and within TEMRA are CD27+CD28+ (pE1,) 
CD27+CD28- (pE2), CD27-CD28- (E).
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Results
Frequencies of N, CM, EM and TEMRA cells in young and 
elderly people
PBMCs from the 37 donors tested were stained with anti-
bodies to CD4, CD8, CD45RA and CCR7. The latter two
markers were used to subdivide CD8+ or CD4+ T-cells
into naïve and different memory subpopulations (Figure
1). Although as expected on the basis of the heterogene-
ous populations examined there is marked inter-individ-
ual variation even at the same age, an age-associated
decrease in the frequency of naïve cells in both CD4+ and
CD8+ cells was observed (Figure 2). However, this
decrease achieved significance only for the CD8+ cells.
There were no age-associated differences in the frequen-
cies of either CD4+ or CD8+ EM cells, but, also as
expected on the basis of previous reports for CD8+ cells,
the proportion of CD8+ TEMRA cells increased signifi-
cantly with age. Again, this was not seen for CD4+ cells. In
contrast, there was a slight but significant increase in
CD4+ CM cells which was not observed for CD8+ CM
cells. This may suggest that whereas the loss of naïve
CD8+ cells results in the accumulation of end-stage differ-
entiated TEMRA cells in the elderly, for CD4+ cells, differ-
entiation proceeds only to CM cells.
Are the frequencies of subsets of CD8 cells defined by 
CD27 and CD28 expression different between young and 
old within the N, CM, EM and TEMRA populations?
An important question in establishing immune biomark-
ers of ageing is whether naïve cells are identical in young
and old people and whether the age-associated differences
are solely quantitative. The same question applies to the
CM, EM and TEMRA subsets. Figure 1 shows the subdivi-
sions of N, CM, EM and TEMRA cells according to the
model of Romero et al. [14] defining 4 subsets of EM and
3 of TEMRA cells. According to this model, both N and
CM cells are exclusively CD27 and CD28 double-positive.
Here, we arbitrarily divided our donors into two groups,
young (mean age = 40) and old (mean age = 87) and plot
the data according to the Romero model. Figure 3A shows
the results of CD27 and CD28 staining within the CD8+
N, CM, EM and TEMRA populations defined in Figure 1.
Results with CD8 T cells from young people in general
support the proposed model, i.e. naïve cells are almost
mostly CD27+CD28+ although a minority does lack
CD28, with very few CD27-CD28- or CD27+CD28-.
There were no CD27-CD28+ CD8 cells. CM cells show
similar phenotypes, whereas EM cells include increased
fractions of CD27-CD28- double negative cells, consistent
with some of them being more highly differentiated (hav-
ing lost CD27 and CD28 expression). However, the
majority remains CD27+CD28+. TEMRA cells, on the
other hand, are mostly CD27-CD28-, with very few
CD27+CD28- and CD27-CD28+ cells, but still retaining a
sizeable population of CD27+CD28+ cells in most indi-
viduals. As previously noted for the proportions of N, CM,
EM and TEMRA cells, there is a great deal of inter-individ-
ual variation in the distribution of these subsets.
Thus, the model of one subset of N, one of CM, and sev-
eral of EM and TEMRA cells as defined by CD27 and
CD28 expression does seem to hold up for CD8 cells from
the young, as previously proposed [14]. However, the sit-
uation is not the same for CD8 cells from the elderly. The
proportion of CD27+CD28+ cells within the naïve subset
is significantly lower than in the young and the fraction of
CD27-CD28+ cells significantly greater (Figure 3A). The
proportion of CD27-CD28+ but not CD27+CD28- naïve
cells is also significantly greater in the elderly than the
young. For CM cells, differences between old and young
reach significance only for the decrease in CD27+CD28+
cells. EM cells have decreased CD27+CD28+ and
increased CD27-CD28- double negative cells in the eld-
erly, with no significant differences between either the
CD27-CD28+ or CD27+CD28- subset. Within the TEMRA
cells, there are no significant differences between young
and old in any subset, consistent with most TEMRA cells
being as fully differentiated as they can be, regardless of
the chronological age of the donor.
Can subsets of CD4 cells also be distinguished on the basis 
of CD27 and CD28 expression and are they different 
between young and old within the N, CM, EM and TEMRA 
populations?
The model applied to CD8 cells above is not well estab-
lished for the CD4 subsets. Age-associated changes in N,
CM, EM and TEMRA subsets are also less well-docu-
mented for CD4 than CD8 cells. Data shown in Figure 2
had confirmed a decrease in naïve cells in the very elderly
and increased proportions of CM cells. It remained possi-
ble that differences between young and old within each of
these populations might be more marked. However, data
shown in Figure 3B suggest that this is unlikely to be the
case. There were no significant differences between N, CM
or TEMRA cells in young and old, although here the EM
cells of the elderly did show significant reductions in
CD27+CD28+ cells and presumably reciprocal increases
in CD27-CD28- cells.
Can further subdivisions within subsets using CD57 and 
KLRG1 be informative in distinguishing between T cell 
subsets from young and old people?
Studies on CD8 cells
Two cell surface NK receptors have been suggested to be
markers of "senescent" T cells; CD57, which is expressed
predominantly on CD8 cells, and KLRG1, which is of
especial interest here because it is expressed on both CD4
as well as CD8 cells. A search for distinguishing features of
the various subsets was first initiated in CD8 cells, as more
likely to yield positive results. Figures. 4A, C examineImmunity & Ageing 2008, 5:6 http://www.immunityageing.com/content/5/1/6
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expression of these markers on "fully" naïve (ie.
CD27+CD28+) and CM cells of the same CD27+CD28+
phenotype, in the same groups of young and old donors.
Almost all such naïve cells fail to express either CD57 or
KLRG1 in either young or old donors, although there are
signs of some cells starting to acquire KLRG1 (but not
CD57) in the elderly. There is one outlying elderly indi-
vidual in particular with a high level of KLRG1+ cells (and
fewer KLRG1- cells) but even this donor's cells do not
express CD57. Within the CD27+CD28+ CM cells, most
individuals, whether young or old, now begin to express
KLRG1, but still none express CD57, consistent with a dif-
ferentiation pathway from naïve to CM marked by expres-
sion of KLRG1 but not CD57.
Data shown in Figure 5A address CD57 and KLRG1
expression by the 4 subsets of CD8+ EM cells. Essentially
all cells within the EM1 subset remain CD57-, but the fre-
quency of KLRG1+ cells is increased compared to the CM
cells (compare Figure 4C). The EM2 subset, defined as
CD27+CD28-, also includes very few CD57+ cells,
although there is the hint of an increased occurrence of
CD57+KLRG1+ cells. The EM4 subset (CD28-CD28+)
appears very similar to the EM2 cells in this respect. How-
ever, the EM3 subset, defined as CD27-CD28-, contains a
sizeable fraction of CD57+KLRG1+ cells. There are very
few CD57+KLRG1- cells in any of the 4 subsets and those
that are present are mostly in the EM3 subset. These find-
ings are consistent with the proposal that the CD27-
CD28- EM3 cells are the most highly differentiated of the
4 EM subsets. Figure 5 also documents a lack of any statis-
tically significant differences between cells from the
young or the elderly regarding any of these subsets. These
data are consistent with differences between the young
and old being due to altered frequencies of subsets and
not differences within subsets and age.
Finally, the CD8 TEMRA cell subpopulations were exam-
ined in the same way (Figure 6A). Again, there are no dif-
ferences between young and old. The number of
KLRG1+CD57+ cells within the CD27-CD28-subset was
greater than in the other two (designated pE1 and pE2
according to this model). It is notable that of all the sub-
sets examined, CD57+KLRG1- cells appear only in what is
proposed to be the most fully differentiated subset, the
CD27-CD28- TEMRA subset.
Studies on CD4 cells
The final questions raised here were whether subdivisions
of CD4 cells could be made in the same way as for CD8
cells, and whether these might reveal differences between
the young and the elderly. Figures 4B and 4D show anal-
ogous data to Figures 4A and 4C but for CD4 rather than
CD8 cells. The overall trend seems comparable: naïve cells
contain very few but some KLRG1+CD57- cells but most
cells are KLRG1-CD57-, whereas CM cells have slightly
larger proportions of CD57-KLRG1+ but no CD57+
KLRG1- cells. Unlike CD8 cells, the CD4+ CM cells did
show significant differences between young and old
donors for all except the CD57+KLRG-1- cells. Data
shown in Figure 5B in general support the same scheme
for CD4 cells as applied to CD8 cells (compare Figure 5A
for CD8). In this case there is a statistically significant dif-
ference between old and young EM1 cells, but unexpect-
edly with fewer CD57-KLRG1+ and more CD57-KLRG1-
cells in the elderly than in the young. No other differences
are statistically significant. Finally, Figure 6B shows data
from CD4 TEMRA cells. Here, the differences between
pE1/2 cells and the CD27-CD28- TEMRA cells are even
more striking than seen for CD8 cells (compare Figure
6A). Thus, although neither pE1 nor pE2 cells contain
CD57+KLRG1+ cells, the majority of cells in this most
highly differentiated subset express both markers.
Discussion
Differentiation stages of CD8 T cells can be ordered
according to the expression of cell surface proteins, with a
popular model describing naïve cells as CD45RA+ CCR7+
and memory cells as either CD45RA- CCR7+ (CM),
CD45RA- CCR7- (EM) or CD45RA+ CCR7- (TEMRA).
However, an absolute correlation between differentiation
state and expression of these two surface molecules can-
not be expected in such dynamic systems. Combinations
of markers, however, may improve the ability to dissect
out different subsets. Thus, naïve CD8 cells express CD27
and CD28, have long telomeres and extensive prolifera-
Main T cells subsets identified in young and old by CD45RA  and CCR7 Figure 2
Main T cells subsets identified in young and old by 
CD45RA and CCR7. Frequencies of CD45RA+CCR7+ 
Naive, CD45RA-CCR7+ CM, CD45-CCR7- EM and 
CD45RA+CCR7- TEMRA CD8+ (open symbols) and CD4+ 
(filled symbols) at different ages in linear regression analysis.
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tive capacity [20]. The use of these markers may also not
be sufficient, but the use of polychromatic flow cytometry
for the first time allows constellations of markers to be
used together for a finer definition of subsets at the single
cell level. Here, we have explored the utility of combining
the above markers with two others thought to be
expressed by late-differentiated T cells, namely, CD57 and
KLRG-1. All these markers together can be used to define
subsets of memory cells with different properties, which
we apply here not only for CD8 cells, but also for CD4
cells, which have not been extensively investigated previ-
ously [21]. Here, we have shown that subdivisions of EM
and TEMRA cells on the basis of CD27 and CD28 expres-
sion can be further dissected by their expression of CD57
and KLRG-1, and moreover, that with the exception of
CD57 expression, the same subsets can be defined in CD4
as well as CD8 cells. Finally, we have sought differences
between young and old people within each of these
newly-defined subsets.
We purposefully selected a heterogeneous cohort of
young and old donors over a wide age range and from dif-
ferent European countries, so that any statistically signifi-
cant differences found are likely to be robustly generally
applicable, independently of genetic or environmental
background. This is likely to be one reason for the large
inter-individual variation observed in many of the tested
parameters. Thus, it is all the more striking that the
expected [22,23] age-associated reduction in the naïve cell
population is clearly seen in CD8+ cells, as well as the
Expression of co-stimulatory molecules CD27 and CD28 Figure 3
Expression of co-stimulatory molecules CD27 and CD28. The main T cell subsets were subdivided according to 
expression of the co-stimulatory molecules CD27 and CD28. Frequencies of CD27-CD28+, CD27+CD28+, CD27-CD28- 
and CD27+CD28- in N, CM, EM and TEMRA in (A) CD8+ and (B) CD4 T cells in young (filled symbols) and the elderly (open 
symbols) are shown. The naïve and CM cells were defined as CD27+CD28+, whereas the EM and TEMRA were divided into 
further subsets according to the model in Figure 1. Significant differences are indicated by asterisks, as in Figure 2.
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increase in TEMRA cells (Figure 2). An age-associated
reduction in naïve CD4+ cells was also observed,
although this did not reach significance, and was accom-
panied by an increase in CM not TEMRA cells (Figure 2).
The expression of the costimulatory receptors CD27 and
CD28 may be used to subdivide CD8 cells [14], demon-
strating 4 populations of CD45RA- CCR7- EM cells and 3
of TEMRA (a CD27-CD28+ subset not being found in the
latter). In general, in CD8 cells from young donors, our
data confirm the presence of these subpopulations,
although we found very few CD27-CD28+ or
CD27+CD28- cells within either the EM or TEMRA sub-
sets. Essentially the same pattern was found in cells from
the elderly too, but interestingly within the EM but not
within the TEMRA populations, there were significant dif-
ferences between young and old for both CD27+CD28+
and CD27-CD28- cells (Figure 3A). This finding is consist-
ent with the idea that subsets of TEMRA cells represent
end-stage differentiated cells regardless of the age of the
host, and which by definition cannot differentiate further.
Within the CD45RA+CCR7+ naïve CD8 cells, the elderly
showed a reduction in CD27+CD28+ cells, an unexpected
finding which could be explained by homeostatic prolif-
eration of these cells with retention of naïve markers but
loss of costimulatory receptors in the elderly. This would
be likely to contribute to the poorer responses of naïve
cells in old individuals, which has been demonstrated in
TCR transgenic animal models, at least for CD4 cells [24].
Alternatively, these cells may not be "fully" mature but
may in fact have re-acquired CCR7 as well as CD45RA,
thus appearing naive. There is a precedent in the literature
for such an event [25]. However, the picture with CD4
Distribution of CD57 and KLRG1 in naive and CM T cells Figure 4
Distribution of CD57 and KLRG1 in naive and CM T cells. The CD27+CD28+ N and CD28+CD27+ CM (A and C) 
CD8+ and (B and D) CD4+ T cells in young (filled symbols) and the elderly (open symbols) were analysed for CD57 and 
KLRG1. Significant differences are indicated by asterisks, as in Figure 2.
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naïve cells was markedly different, with essentially all of
them remaining CD27+CD28+, regardless of the age of
the donor (Figure 3B). These data are consistent with the
maintenance of a higher degree of both qualitative and
quantitative integrity of the CD4 subset naïve potential
than the CD8 with increasing donor age. However, as with
CD8 cells, the CD4 subset also showed an increase of the
CD27-CD28- EM3 cells at the expense of the
CD27+CD28+ EM1 cells. This might also compromise the
ability of previously activated effector memory cells to be
reactivated, due to the lack of two major costimulatory
receptors.
CD57 is a negative NK receptor also expressed on CD8 but
not on CD4 cells, whereas KLRG-1 is a negative NK recep-
tor expressed by both CD4 and CD8 cells [15]. Both have
been dubbed "senescence" markers, and their absence
from "fully" naïve and CM cells from the old as well as the
young (Figure 4) is consistent with this. Both markers
together identify the latest state of differentiation within
the respective subsets. On CD8 cells, all 4 possible pheno-
types are present (Figure 5A), whereas CD57 is not
expressed on CD4 cells, not even from old donors, with
two exceptions: EM3 cells are the only EM subset express-
ing any CD57, again independent of the age of the donor,
but only by a minority of this subset and only by those
cells already expressing KLRG-1 (Figure 5B). This suggests
that a very small proportion of effector memory CD4 cells
can indeed express CD57, and that EM3 cells are the most
differentiated subset thereof, as with their CD8 counter-
parts. The other CD4 subset which expresses CD57 is the
most differentiated of all: the CD27-CD28- TEMRA sub-
Distribution of CD57 and KLRG1 in different EM T cell subsets Figure 5
Distribution of CD57 and KLRG1 in different EM T cell subsets. According to the subset model depicted in Figure 1, 
the EM CD8+ (A) and CD4+ (B) were subdivided into CD27+CD28+ EM1, CD27+CD28- EM2, CD27-CD28- EM 3 and 
CD27-CD28+ EM4 T cells in young (filled symbols) and the elderly (open symbols) and analyzed for the expression CD57 and 
KLRG1. Significant differences are indicated by asterisks, as in Figure 2.
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set, again only on cells which are KLRG-1+ as well (Figure
6B).
By labelling whole PBMC with the stable membrane dye
CFSE, cell division after stimulation can be tracked over
4–6 or more divisions. Applying this technique to CD4
and CD8 cells from young individuals assessed by the
same surface markers as described above, and assuming
that the more differentiated a cell is the less it can prolif-
erate, we are in the process of accumulating data which are
consistent with the model derived from the differential
expression of CD45RA, CCR7, CD27, CD28, CD57 and
KLRG-1 (data not shown). Reciprocally, at least for CD8
cells, the accumulation of perforin and Granzyme A is also
consistent with the same differentiation scheme (data not
shown). This scheme supports the notion that T cells dif-
ferentiate sequentially through the stages
N→CM→EM1→EM2→pE1→pE2→EM4→EM3→E and
that the major but not the only differences, between cells
from young and old donors reside in the relative propor-
tions of these different subsets present. Nonetheless, using
CD27 and CD28, age-associated differences primarily
within CD8 but not CD4 subsets can be discerned,
whereas using CD57 and KLRG-1 reveals such differences
predominantly within the CD4 but not the CD8 subsets.
Conclusion
Polychromatic flow cytometry is proving to be a powerful
tool for examining changes in immune parameters in the
elderly. The data provided here sought "lowest common
denominator" changes in the distribution of both CD4
and CD8 subsets in different European populations over
Distribution of CD57 and KLRG1 in different TEMRA T cell subsets Figure 6
Distribution of CD57 and KLRG1 in different TEMRA T cell subsets. According to the subset model depicted in Fig-
ure 1, the EM CD8+ (A) and CD4+ (B) were subdivided into CD27+CD28+ pE1, CD27+CD28- pE2, CD27-CD28- E T cells in 
young (filled symbols) and the elderly (open symbols) and analyzed for the expression CD57 and KLRG1. Significant differences 
are indicated by asterisks, as in Figure 2.
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a range of ages from early middle aged to very old. By
combining analyses using antibodies to CD27, CD28,
CCR7, CD45RA, CD57 and KLRG-1, the results presented
here confirm the robustness of the decrease in naïve and
increase of late-differentiated CD8 cells with age, with a
similar tendency in CD4 cells, in different populations
with dissimilar genetic, nutritional and pathogen-expo-
sure backgrounds. Combined with functional assays, this
approach will facilitate the analysis of age-associated
immune alterations in humans in unprecedented detail.
Methods
Donors
In order to encompass a broad (although exclusively Cau-
casian) population, cryopreserved PBMC were collected
from several different European countries with a mean age
of 40 (53% female) or 87 (66% female). Because this
study was aimed at determining the most robust and
reproducible differences between old and young donors,
they were not rigorously selected for health status, nutri-
tion, infection etc. They were from Italy, Sweden, Bulgaria
and Germany, thus encompassing multiple genetic and
environmental backgrounds. These donors were overtly
healthy but were not SENIEUR-compliant, in order to
study a more representative group of elderly. This
approach obviously makes it more difficult to detect sig-
nificant differences within such a heterogeneous group,
but it is our belief that when significant differences do
emerge in such a study, they are likely to be of more basic
import than those seen only in highly selected subgroups.
Gating strategy for CD8+ T cells Figure 7
Gating strategy for CD8+ T cells. (A) Viable Lymphocytes were gated and then selected for either CD8+ or CD4+ T cells. 
(B) The CD8+ T cells were subdivided into the main T cell subsets using CD45RA and CCR7. (C) The CD45RA+CCR7+ N, 
CD45RA-CCR7+ CM, CD45-CCR7- EM and CD45RA+ CCR7- TEMRA CD8+ T cells were plotted against CD27 and CD28. 
According to the subset model (Figure 1) the different CD27 and CD28 dependent subpopulations (D) CM, (E) N, (F) EM and 
(G) TEMRA subsets were analyzed for CD57 and KLRG1.
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Thus, although infection with herpes viruses, especially
CMV, is known to alter certain immune parameters, even
this was also not taken into account in this study. Hence,
we argue that any differences observed in this very hetero-
geneous group of subjects are more likely to reflect basic
age-related alterations than influences of genetics, nutri-
tion, infection etc.
Antibodies
Direct immunofluorescence was performed with pre-
titrated anti-CD4-PacificBlue, CD28-AlexaFluor700 (Bio-
Legend, Biozol, Eching, Germany), CD8-APC-Cy7, CD27-
APC CCR7-PE-Cy7 (Becton Dickinson, Heidelberg, Ger-
many) and CD45RA-PE-Cy5.5 (Invitrogen, Karlsruhe,
Germany). CD57 was from Immunotools, Friesoythe,
Germany. For indirect immunofluorescence, anti-human
KLRG1 (clone 13A2), kindly provided by Prof. H.P.
Pircher, Freiburg, was used as primary antibody. As sec-
ondary antibody, Pacific Orange-goat anti-mouse IgG
(Invitrogen) was used. For blocking, human immu-
noglobulin GAMUNEX (Bayer, Leverkusen, Germany) or
mouse serum (Caltag/Invitrogen, Karlsruhe, Germany)
were used. The cell viability was determined with Ethid-
ium monoazide (EMA) (Invitrogen). All staining steps
were performed in PFEA buffer (PBS, 2% FCS, 2 mM
EDTA and 0.01% Azide).
Staining
For each experiment, cells or mouse or hamster/rat κ-
chain Comp Beads (Becton Dickinson) were stained with
Gating strategy for CD4+ T cells Figure 8
Gating strategy for CD4+ T cells. (A) Viable Lymphocytes were gated and then selected for either CD8+ or CD4+ T cells. 
(B) The CD4+ T cells were subdivided into the main T cell subsets using CD45RA and CCR7. (C) The CD45RA+CCR7+ N, 
CD45RA-CCR7+ CM, CD45-CCR7- EM and CD45RA+ CCR7- TEMRA CD4+ T cells were plotted against CD27 and CD28. 
According to the subset model (Figure 1) the different CD27 and CD28 dependent subpopulations (D) CM, (E) N, (F) EM and 
(G) TEMRA subsets were analyzed for CD57 and KLRG1.
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corresponding fluorochrome-labelled antibodies and
incubated for 20 min at 4°C in the dark. As unstained
negative controls we used negative Comp Beads (Becton
Dickinson). After washing with PFEA, the cells or beads
were resuspended in 200 μl PFEA and measured using an
LSR-II flow cytometer and the acquisition software BD
FACSDiva (Becton Dickinson). The spectral overlap
between all channels was calculated automatically by the
BD FACSDiva software, after measuring negative and sin-
gle-colour controls. For additional data analysis, Flowjo
7.2.2 (Treestar Inc, San Carlos, CA) was used. Careful con-
trol experiments indicated that cryopreservation and
thawing of the PBMC did not alter the pattern of staining
observed for the major subsets studied here (Larbi et al.,
manuscript in preparation).
For data analysis the following populations were gated in
sequence. The first gate was Time vs. SSC-A to detect dif-
ferences in the flow. To exclude dead cells, the EMA-nega-
tive population was selected in FSC-A vs. EMA to identify
lymphocytes within the FSC-A vs. SSC-A dot plot for fur-
ther analysis. Different fluorochrome-stained populations
were highlighted by XY-quadrants and gates to obtain the
corresponding statistics including counted events, per-
centage of parent, percentage of total, mean and median
fluorescence intensity. Gating strategy is shown in Figures
7 and 8.
Statistics
All statistical analysis were performed with Graphpad
Prism 4.03 and 5.0. Non-parametric Mann-Whitney U test
was used for comparison of two independent groups.
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